In this article published in Drug Development & Delivery, Pascale Diesel and Lev Gerlovin discuss how as industry works to advance cell and gene therapy development, the debate over new approaches to structuring and financial clinical research continues.
Click here to read the article.
CRA Insights: Life Sciences
CRA’s Life Sciences Litigation team provides periodic summaries of notable developments in litigation. In this issue, we share an update on a Supreme Court...